Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Saved in:
| Title: | Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Ravera F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Internal Medicine, University of Genoa, Genova, Italy., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy., Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Malgeri A; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy., Rossetti S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Valença LB; Instituto D'Or de Pesquisa e Ensino (IDOR), Salvador, Brazil.; Hospital Sao Rafael, Salvador, Brazil., Oliveira TM; Instituto D'Or de Pesquisa e Ensino (IDOR), Salvador, Brazil.; Hospital Sao Rafael, Salvador, Brazil., Vauchier C; Thoracic Oncology Unit, Bichat-Claude Bernard Hospital, Paris, France., Pereira Mestre R; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland., Modesti M; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland., Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Procopio G; Oncology Unit, ASST Cremona, Cremona, CR, Italy., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, Florence 50134, Italy. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Mar 03; Vol. 15, pp. 17588359231156147. Date of Electronic Publication: 2023 Mar 03 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359231156147 |
